成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

RD International Technology Co., Limited??? ?? ??? ?????.

?? ?:RD International Technology Co., Limited
??:-
???:market@ubiochem.com
??:China
URL: www.ruidiresearch.com
? ?? ?:9272

?? ????

CX-6258 hydrochloride hydrateCX6258??????1353858-99-7C26H27Cl2N3O4
CX-6258 hydrochloride1353859-00-3C26H25Cl2N3O3
Zorifertinib1626387-80-1C22H23ClFN5O3
Lifirafenib1446090-79-4C25H17F3N4O3
CHZ8681895895-38-1C22H19F2N5O2
Lavendustin A125697-92-9C21H19NO6
PIM-447 dihydrochloride1820565-69-2C24H23F3N4O
JAK3-IN-11805787-93-2C26H30ClN7O2
Ilginatinib maleate1354799-87-3C25H24FN7O4
Ilginatinib1239358-86-1C21H20FN7
Ilginatinib hydrochlorideNS-018(???)1239358-85-0C21H21ClFN7
Naquotinib mesylate????(?????)1448237-05-5C31H46N8O6S
EGFR-IN-31660963-42-7C29H28F2N6O2
Avitinib maleate1557268-88-8C30H30FN7O6
NRC-2694936446-61-6C24H26N4O3
PF-064599881428774-45-1C19H22ClN7O3
Neratinib????698387-09-6C30H29ClN6O3
Tarlox-TKI2135696-72-7C19H18BrClN6O
Ruxolitinib (S enantiomer)S-?????(INCB018424)941685-37-6C17H18N6
Lestaurtinib????111358-88-4C26H21N3O4
Gefitinib hydrochloride184475-55-6C22H25Cl2FN4O3
Gefitinib D8????D8857091-32-8C22H24ClFN4O3
Lapatinib ditosylate388082-77-7C36H34ClFN4O7S2
Mutated EGFR-IN-11421372-66-8C25H31N7O
Osimertinib dimesylate2070014-82-1C29H37N7O5S
Niclosamide olamine????????????1420-04-8C15H15Cl2N3O5
Khellin82-02-0C14H12O5
Mutant EGFR inhibitor1421373-62-7C27H30ClN7O2
CP-724714383432-38-0C27H27N5O3
NVP-BSK805 dihydrochloride1942919-79-0C27H29ClF2N6O
Homoharringtonine??????26833-87-4C29H39NO9
NSC 74859501919-59-1C16H15NO7S
Icotinib Hydrochloride????(???)1204313-51-8C22H22ClN3O4
Baricitinib phosphate????????1187595-84-1C16H20N7O6PS
RGB-286638784210-87-3C29H37Cl2N7O4
AZD12081204144-28-4C21H21N3O2S
Tyrphostin 23118409-57-7C10H6N2O2
Rociletinib hydrobromide1446700-26-0C27H29BrF3N7O3
Osimertinib mesylate?????1421373-66-1C29H37N7O5S
AG-825149092-50-2C19H15N3O3S2
Cerdulatinib hydrochloride1369761-01-2C20H28ClN7O3S
SH-4-541456632-40-8C29H27F5N2O5S
GDC-03391428569-85-0C20H22F3N7OS
Itacitinib adipate1334302-63-4C32H33F4N9O5
Tarloxotinib bromide1636180-98-7C24H24Br2ClN9O3
Ochromycinone111540-00-2C19H14O4
TCS PIM-1 1491871-58-0C18H11BrN2O2
CX-62581202916-90-2C26H24ClN3O3
Napabucasin2-?????-1,4-?????83280-65-3C14H8O4
GLPG0634 analog1206101-20-3C23H18N6O2
Alantolactone546-43-0C15H20O2
Cryptotanshinone35825-57-1C19H20O3
Diosgenin?????512-04-9C27H42O3
Artesunate88495-63-0C19H28O8
Cyasterone17086-76-9C29H44O8
Nitidine chloride13063-04-2C21H18NO4+
Curculigoside85643-19-2C22H26O11
Scutellarin27740-01-8C21H18O12
Corylifol A775351-88-7C25H26O4
Tephrosin76-80-2C23H22O7
Brevilin A16503-32-5C20H26O5
β-Hydroxyisovalerylshikonin??-????????????7415-78-3C21H24O7
Astragaloside VI??VI84687-45-6C47H78O19
Reticuline485-19-8C19H23NO4
Triacetylresveratrol??????????????42206-94-0C20H18O6
Hispidulin1447-88-7C16H12O6
Mogrol88930-15-8C30H52O4
Sulforaphene592-95-0C6H9NOS2
Ginsenoside Rk1494753-69-4C42H70O12
Arnicolide D34532-68-8C19H24O5
Garcinone C76996-27-5C23H26O7
Coumermycin A1??????A14434-05-3C55H59N5O20
EGFR Protein Tyrosine Kinase Substrate945830-38-6C48H73N11O17
Cetuximab????205923-56-4C107H179N35O36S7
Trastuzumab?? ?? ??180288-69-1C10H14N6O5
Pertuzumab????380610-27-5C17H27NO2
ZD-4190413599-62-9C19H16BrFN6O2
GNE-4951449277-10-4C22H20FN5O2
TBHQ2-t-????????1948-33-0C10H14O2
M26981379545-95-5C21H19ClF3N5O
RAF7091628838-42-5C28H29F3N4O4
(E)-Necrosulfonamide1360614-48-7C18H15N5O6S2
APS-2-792002381-25-9C23H21N3O3
EMI562414374-41-5C21H20N2O3
BD750892686-59-8C14H13N3OS
SGI-17761025065-69-3C20H22F3N5O
Tesevatinib781613-23-8C24H25Cl2FN4O2
Afatinib impurity 111402086-20-7C21H18ClFN4O3
AG-1478153436-53-4C16H14ClN3O2
Oclacitinib maleate1640292-55-2C19H27N5O6S
(Rac)-JBJ-04-125-022140807-05-0C29H26FN5O3S
Mobocertinib1847461-43-1C32H39N7O4
Mobocertinib succinate2389149-74-8C36H45N7O8
CK2/ERK8-IN-11085822-09-8C11H9Br4N3O2
Chrysophanol481-74-3C15H10O4
JCN0372305154-31-6C16H11BrFN3O2
JAK2-IN-6353512-04-6C14H10ClN3OS2
NCB-08461792999-26-8C21H21N5O2
GS-4442171262041-49-5C23H21N7O
LY32149961951483-29-6C22H27N7O2S
Copyright 2019 ? ChemicalBook. All rights reserved